Company news

TScan Therapeutics, Inc. news in 2025

TScan Therapeutics, Inc.'s news releases, calls and decks from 2025, newest first.

View company

TScan Therapeutics Announces Positive Updated Data from the ALLOHA™ Phase 1 Heme Trial at the 67th American Society of Hematology Annual Meeting and Exposition

December 6, 2025

TScan Therapeutics to Host Virtual KOL Event to Discuss Clinical Updates from the ALLOHA™ Phase 1 Trial and Future Market Opportunities

December 3, 2025

TScan Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

November 12, 2025

TScan Therapeutics to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference

November 5, 2025

TScan Therapeutics Reaches Agreement with FDA on Pivotal Study Design for TSC-101 and Announces Strategic Prioritization to Advance TSC-101 and Extend Cash Runway into H2 2027

November 3, 2025

TScan Therapeutics Announces Upcoming Oral and Poster Presentations at the American College of Rheumatology Convergence 2025

September 17, 2025

TScan Therapeutics to Participate in Upcoming Investor Conferences

September 3, 2025

TScan Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

August 12, 2025

TScan Therapeutics Announces Upcoming Presentation at the Jefferies Global Healthcare Conference

May 28, 2025

TScan Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

May 6, 2025

TScan Therapeutics Announces Upcoming Presentation at the American Society of Gene and Cell Therapy 28th Annual Meeting

April 28, 2025

TScan Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference

March 31, 2025

TScan Therapeutics Appoints Commercial Leader Stephen Camiolo as Senior Vice President, Market Access

March 27, 2025

TScan Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

March 5, 2025

TScan Therapeutics Announces Upcoming Presentation at the TD Cowen 45th Annual Health Care Conference

February 27, 2025

TScan Therapeutics to Participate in the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference

February 18, 2025

Decks in 2025